CDC Celebrates 25th Anniversary of the Discovery of the Hepatitis C Virus

Article

Twenty-five years ago the Centers for Disease Control and Prevention (CDC) played a pivotal role in the discovery of the virus that causes hepatitis C. After the isolation of HCV, implementation of screening of blood products and organs for donation led to a decrease in rates of HCV infection between 1990 and 2009. In spite of these successes, HCV still remains a serious threat, both domestically and abroad. HCV remains the most common chronic bloodborne infection in the United States, affecting approximately 3.9 million individuals. However, up to 50 percent of HCV-infected persons are unaware of their infection. Globally, there are 180 million people who are chronically infected with the virus, and 3 million to 4 million new infections occur every year.

Recent therapeutic advances hold the potential to halt the progression of HCV infection and disease. While HCV-infected persons can be effectively treated, more effort is needed to screen, diagnosis, treat and provide continuity of care. A Public Health Grand Rounds to be held on June 17, 2014, at 1 p.m. ET will discuss how new screening guidelines, testing methods and therapeutic advances will provide us with an opportunity to improve individual outcomes and to eventually eliminate HCV infection.

The Public Health Grand Rounds will be presented by:

John W. Ward, MD
Director, Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, CDC
“The Epidemiology of Hepatitis C: How Did We Get Here?

David Thomas, MD, MPH
Stanhope Bayne Jones Professor of Medicine
Chief of Infectious Diseases Johns Hopkins School of Medicine
“Hepatitis C: The Curative Era”

Phillip O. Coffin, MD, MIA
Director of Substance Use Research
San Francisco Department of Public Health University of California San Francisco
“Steps toward Ending Hepatitis C in the U.S.”

The event will be facilitated by:

John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds
Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds
Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds
 
Grand Rounds is available for continuing education. Learn more about continuing education on the Grand Rounds FAQ.

Source: CDC

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
David J. Weber, MD, MPH, president of the Society for Healthcare Epidemiology of America
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
© 2025 MJH Life Sciences

All rights reserved.